| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Petros Pharmaceuticals, Inc. (PTPI) has 4 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. PTPI is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 4.42M | $27.8K | - | |
| Dir | 1.89M | $11.9K | - | |
| Other | 520.0K | $3.3K | - | |
| Dir | 506.3K | $3.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2021 | Shulman John D | Director, 10% Owner | Buy | 145,773 | $3.43 | $500,001.39 | +2.6% | |
| Nov 29, 2021 | Shulman John D | Director, 10% Owner | Buy | 500,000 | $3.00 | $1,500,000.00 | +9.9% | |
| Oct 18, 2021 | Shulman John D | Director, 10% Owner | Buy | 1,661,807 | $1.72 | $2,849,999.01 | +48.9% |